CA2376406A1 - Recepteur couple a la proteine g exprime dans le cerveau - Google Patents

Recepteur couple a la proteine g exprime dans le cerveau Download PDF

Info

Publication number
CA2376406A1
CA2376406A1 CA002376406A CA2376406A CA2376406A1 CA 2376406 A1 CA2376406 A1 CA 2376406A1 CA 002376406 A CA002376406 A CA 002376406A CA 2376406 A CA2376406 A CA 2376406A CA 2376406 A1 CA2376406 A1 CA 2376406A1
Authority
CA
Canada
Prior art keywords
con167
transmembrane receptor
polypeptide
antibody
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002376406A
Other languages
English (en)
Inventor
Gabriel Vogeli
Linda S. Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2376406A1 publication Critical patent/CA2376406A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Anesthesiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention porte sur un gène codant pour un récepteur couplé à la protéine G dit CON167 jusqu'alors inconnu; sur les produits d'assemblage et cellules hôtes de recombinaison comportant ledit gène; sur le polypeptide CON 167 codé par ledit gène; sur des anticorps du polypeptide; et sur des procédés d'obtention et d'utilisation des précédents.
CA002376406A 1999-08-19 2000-08-08 Recepteur couple a la proteine g exprime dans le cerveau Abandoned CA2376406A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37756399A 1999-08-19 1999-08-19
US09/377,563 1999-08-19
PCT/US2000/021566 WO2001014554A1 (fr) 1999-08-19 2000-08-08 Recepteur couple a la proteine g exprime dans le cerveau

Publications (1)

Publication Number Publication Date
CA2376406A1 true CA2376406A1 (fr) 2001-03-01

Family

ID=23489628

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002376406A Abandoned CA2376406A1 (fr) 1999-08-19 2000-08-08 Recepteur couple a la proteine g exprime dans le cerveau

Country Status (5)

Country Link
EP (1) EP1204747A1 (fr)
JP (1) JP2003507068A (fr)
AU (1) AU6624500A (fr)
CA (1) CA2376406A1 (fr)
WO (1) WO2001014554A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2442581A1 (fr) * 2001-03-27 2002-10-03 Inscent, Inc. Procedes efficaces destines a isoler des recepteurs fonctionnels couples a la proteine g et a identifier des effecteurs actifs, des procedes efficaces destines a isoler des proteines impliquees dans l'odorat et des procedes efficaces destines a isoler et a identifier des effecteurs actifs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874243A (en) * 1997-03-28 1999-02-23 Smithkline Beecham Corporation OLRCC15 receptor

Also Published As

Publication number Publication date
AU6624500A (en) 2001-03-19
WO2001014554A1 (fr) 2001-03-01
JP2003507068A (ja) 2003-02-25
EP1204747A1 (fr) 2002-05-15

Similar Documents

Publication Publication Date Title
US7456255B2 (en) Nogo receptor homologs that decrease inhibition of axonal elongation
US20050112660A1 (en) Novel G protein-coupled receptors
US20030003451A1 (en) Novel G protein-coupled receptors
AU1575601A (en) G protein-coupled receptors expressed in brain
WO2001066750A2 (fr) Nouveaux recepteurs couples a la proteine g
JPH10201485A (ja) 新規ｇ−蛋白質結合レセプターｈｕｖｃｔ３６
US20050074808A1 (en) G protein-coupled receptor expressed in brain
US20040091928A1 (en) G protein-coupled receptors expressed in brain
CA2376406A1 (fr) Recepteur couple a la proteine g exprime dans le cerveau
JPH11511030A (ja) 新規なヒトｇ−蛋白質結合レセプター
WO2001068858A2 (fr) Nouveaux recepteurs couples a la proteine g
AU2004210549A1 (en) G protein-coupled receptor expressed in brain
US20030170779A1 (en) Novel G protein-coupled receptors
US20050214790A1 (en) Novel G protein-coupled receptors
US20050069976A1 (en) Protein-coupled receptor
US20020137132A1 (en) Novel G protein-coupled receptors
US20020052021A1 (en) Novel G protein-coupled receptors
US20030175857A1 (en) Novel G protein-coupled receptor
US20030032784A1 (en) Novel G protein-coupled receptors
US20030032019A1 (en) Novel G protein-coupled receptors
US20020198368A1 (en) Novel G protein-coupled receptors
WO2001081407A2 (fr) Nouveau recepteur couple aux proteines g
WO2001090149A2 (fr) Recepteurs couple a une proteine g
WO2001062798A2 (fr) Nouveaux recepteurs couples a la proteine g
EP1686135A1 (fr) Récepteurs couplés à la protéine G

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead